Previous close | N/A |
Open | N/A |
Bid | N/A |
Ask | N/A |
Strike | N/A |
Expiry date | N/A |
Day's range | N/A - N/A |
Contract range | N/A |
Volume | |
Open interest | N/A |
Amgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month and older with Philadelphia chromosome-negative B-ALL in the consolidation phase, regardless of MRD status.
We can readily understand why investors are attracted to unprofitable companies. Indeed, Twist Bioscience ( NASDAQ:TWST...
Here is how DaVita HealthCare (DVA) and Twist Bioscience (TWST) have performed compared to their sector so far this year.